Guangdong Raynovent Biotech Co., Ltd
Clinical trials sponsored by Guangdong Raynovent Biotech Co., Ltd, explained in plain language.
-
New flu drug for kids enters final testing phase
Disease control OngoingThis study is testing an investigational medicine called ZSP1273 to treat influenza A (the flu) in otherwise healthy children aged 2 to 11. The main goals are to see if the medicine safely helps kids feel better faster by reducing their flu symptoms. Researchers will measure how …
Phase: PHASE3 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New flu pill trial aims to help teens recover faster
Disease control OngoingThis study is testing whether an experimental tablet called ZSP1273 helps teenagers with influenza A feel better faster than a placebo. Researchers are comparing the two treatments in 157 participants aged 12-17 who have had flu symptoms for less than two days. The main goal is t…
Phase: PHASE3 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Scientists test new Weight-Loss Drug's safety with heart and cholesterol meds
Knowledge-focused OngoingThis early-stage study aims to understand how a new investigational drug for obesity, called RAY1225, interacts with four common medications (warfarin, atorvastatin, metformin, and digoxin). It will enroll 32 healthy participants to measure the drug levels in the body and check f…
Phase: PHASE1 • Sponsor: Guangdong Raynovent Biotech Co., Ltd • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC